_id

690db37dccc777a4e85d0cec

Ticker

AVDL

Name

Avadel Pharmaceuticals PLC

Exchange

NASDAQ

Address

10 Earlsfort Terrace, Dublin, Ireland, D02 T380

Country

USA

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Currency

USD

Website

https://www.avadel.com

Description

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is the LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin 2, Ireland.

Last Close

21.39

Volume

8914307

Current Price

21.36

Change

-0.1402524544179576

Last Updated

2025-11-28T12:35:08.231Z

Image

data:image/webp;base64,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

Ipo Date

1996-06-07T00:00:00.000Z

Market Cap

2097009280

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.7671514285714285

Sentiment Sources

35

Rating

4.75

Target Price

20.9375

Strong Buy

6

Buy

2

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

77467000

Cost Of Revenue

-3001000

Gross Profit

80468000

Operating Expenses

78531000

Operating Income

1937000

Interest Expense

2415000

Pretax Income

54000

Net Income

20000

Eps

0.0001974801532445989

Dividends Per Share

-

Shares Outstanding

97991088

Income Tax Expense

34000

EBITDA

3584000

Operating Margin

2.5004195334787713

Total Other Income Expense Net

-1883000

Cash

79813000

Short Term Investments

11764000

Receivables

42444000

Inventories

23905000

Total Current Assets

172226000

Property Plant Equipment

3011000

Total Assets

199448000

Payables

12581000

Short Term Debt

740000

Long Term Debt

-

Total Liabilities

101223000

Equity

98225000

Depreciation

1115000

Change In Working Capital

-3832925

Cash From Operations

23259760

Capital Expenditures

10760

Cash From Investing

-8790826

Cash From Financing

2634754

Net Change In Cash

16411000

PE

0

PB

22.02347019597862

ROE

0.020361415118350726

ROA

0.010027676386827644

FCF

23249000

Fcf Percent

0.3001148876295713

Piotroski FScore

4

Health Score

51

Deep Value Investing Score

6

Defensive Investing Score

6

Dividend Investing Score

3

Economic Moat Investing Score

5.3

Garp Investing Score

4

Growth Investing Score

4

Momentum Investing Score

5.5

Net Net Investing Score

4

Quality Investing Score

4

Value Investing Score

5.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

77467000

Quarters > 0 > income Statement > cost Of Revenue

-3001000

Quarters > 0 > income Statement > gross Profit

80468000

Quarters > 0 > income Statement > operating Expenses

78531000

Quarters > 0 > income Statement > operating Income

1937000

Quarters > 0 > income Statement > interest Expense

2415000

Quarters > 0 > income Statement > pretax Income

54000

Quarters > 0 > income Statement > net Income

20000

Quarters > 0 > income Statement > eps

0.0001974801532445989

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

101276000

Quarters > 0 > income Statement > income Tax Expense

34000

Quarters > 0 > income Statement > EBITDA

3584000

Quarters > 0 > income Statement > operating Margin

2.5004195334787713

Quarters > 0 > income Statement > total Other Income Expense Net

-1883000

Quarters > 0 > balance Sheet > cash

79813000

Quarters > 0 > balance Sheet > short Term Investments

11764000

Quarters > 0 > balance Sheet > receivables

42444000

Quarters > 0 > balance Sheet > inventories

23905000

Quarters > 0 > balance Sheet > total Current Assets

172226000

Quarters > 0 > balance Sheet > property Plant Equipment

3011000

Quarters > 0 > balance Sheet > total Assets

199448000

Quarters > 0 > balance Sheet > payables

12581000

Quarters > 0 > balance Sheet > short Term Debt

740000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

101223000

Quarters > 0 > balance Sheet > equity

98225000

Quarters > 0 > cash Flow > net Income

20000

Quarters > 0 > cash Flow > depreciation

1115000

Quarters > 0 > cash Flow > change In Working Capital

-3832925

Quarters > 0 > cash Flow > cash From Operations

23259760

Quarters > 0 > cash Flow > capital Expenditures

10760

Quarters > 0 > cash Flow > cash From Investing

-8790826

Quarters > 0 > cash Flow > cash From Financing

2634754

Quarters > 0 > cash Flow > net Change In Cash

16411000

Quarters > 0 > ratios > PE

0.0001974801532445989

Quarters > 0 > ratios > PB

22.02347019597862

Quarters > 0 > ratios > ROE

0.020361415118350726

Quarters > 0 > ratios > ROA

0.010027676386827644

Quarters > 0 > ratios > FCF

23249000

Quarters > 0 > ratios > Piotroski FScore

4

Quarters > 0 > ratios > fcf Percent

0.3001148876295713

Quarters > 0 > health Score

51

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

68129000

Quarters > 1 > income Statement > cost Of Revenue

6366000

Quarters > 1 > income Statement > gross Profit

61763000

Quarters > 1 > income Statement > operating Expenses

52879000

Quarters > 1 > income Statement > operating Income

8884000

Quarters > 1 > income Statement > interest Expense

2355000

Quarters > 1 > income Statement > pretax Income

6495000

Quarters > 1 > income Statement > net Income

9665000

Quarters > 1 > income Statement > eps

0.09754054517747031

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

99087000

Quarters > 1 > income Statement > income Tax Expense

-3170000

Quarters > 1 > income Statement > EBITDA

9918000

Quarters > 1 > income Statement > operating Margin

13.039968295439532

Quarters > 1 > income Statement > total Other Income Expense Net

-2389000

Quarters > 1 > balance Sheet > cash

63402000

Quarters > 1 > balance Sheet > short Term Investments

18145000

Quarters > 1 > balance Sheet > receivables

40631000

Quarters > 1 > balance Sheet > inventories

23484000

Quarters > 1 > balance Sheet > total Current Assets

159105000

Quarters > 1 > balance Sheet > property Plant Equipment

11008000

Quarters > 1 > balance Sheet > total Assets

187157000

Quarters > 1 > balance Sheet > payables

10114000

Quarters > 1 > balance Sheet > short Term Debt

723000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

96448000

Quarters > 1 > balance Sheet > equity

90709000

Quarters > 1 > cash Flow > net Income

9665000

Quarters > 1 > cash Flow > depreciation

1068000

Quarters > 1 > cash Flow > change In Working Capital

-2507000

Quarters > 1 > cash Flow > cash From Operations

12697000

Quarters > 1 > cash Flow > capital Expenditures

181000

Quarters > 1 > cash Flow > cash From Investing

-8254000

Quarters > 1 > cash Flow > cash From Financing

982000

Quarters > 1 > cash Flow > net Change In Cash

7032000

Quarters > 1 > ratios > PE

0.09754054517747031

Quarters > 1 > ratios > PB

23.332837094444873

Quarters > 1 > ratios > ROE

10.654951548357936

Quarters > 1 > ratios > ROA

5.164113551723953

Quarters > 1 > ratios > FCF

12516000

Quarters > 1 > ratios > Piotroski FScore

4

Quarters > 1 > ratios > fcf Percent

0.18371031425677758

Quarters > 1 > health Score

63

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

52511000

Quarters > 2 > income Statement > cost Of Revenue

5577000

Quarters > 2 > income Statement > gross Profit

46934000

Quarters > 2 > income Statement > operating Expenses

49935000

Quarters > 2 > income Statement > operating Income

-3001000

Quarters > 2 > income Statement > interest Expense

2238000

Quarters > 2 > income Statement > pretax Income

-4842000

Quarters > 2 > income Statement > net Income

-4920000

Quarters > 2 > income Statement > eps

-0.050931149781058165

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

96601000

Quarters > 2 > income Statement > income Tax Expense

78000

Quarters > 2 > income Statement > EBITDA

-1779000

Quarters > 2 > income Statement > operating Margin

-5.714993049075432

Quarters > 2 > income Statement > total Other Income Expense Net

-1841000

Quarters > 2 > balance Sheet > cash

56370000

Quarters > 2 > balance Sheet > short Term Investments

10114000

Quarters > 2 > balance Sheet > receivables

41581000

Quarters > 2 > balance Sheet > inventories

20406000

Quarters > 2 > balance Sheet > total Current Assets

139258000

Quarters > 2 > balance Sheet > property Plant Equipment

11665000

Quarters > 2 > balance Sheet > total Assets

167949000

Quarters > 2 > balance Sheet > payables

9116000

Quarters > 2 > balance Sheet > short Term Debt

706000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

93879000

Quarters > 2 > balance Sheet > equity

74070000

Quarters > 2 > cash Flow > net Income

-4920000

Quarters > 2 > cash Flow > depreciation

825000

Quarters > 2 > cash Flow > change In Working Capital

-8390000

Quarters > 2 > cash Flow > cash From Operations

-8232000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

12317000

Quarters > 2 > cash Flow > cash From Financing

690000

Quarters > 2 > cash Flow > net Change In Cash

4999000

Quarters > 2 > ratios > PE

-0.050931149781058165

Quarters > 2 > ratios > PB

27.857396516808425

Quarters > 2 > ratios > ROE

-6.642365330093155

Quarters > 2 > ratios > ROA

-2.92946072914992

Quarters > 2 > ratios > FCF

-8232000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-0.15676715354878026

Quarters > 2 > health Score

16

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

50410000

Quarters > 3 > income Statement > cost Of Revenue

4812000

Quarters > 3 > income Statement > gross Profit

45598000

Quarters > 3 > income Statement > operating Expenses

48895000

Quarters > 3 > income Statement > operating Income

-3297000

Quarters > 3 > income Statement > interest Expense

2702000

Quarters > 3 > income Statement > pretax Income

-4963000

Quarters > 3 > income Statement > net Income

-5043000

Quarters > 3 > income Statement > eps

-0.05231599149333472

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

96395000

Quarters > 3 > income Statement > income Tax Expense

80000

Quarters > 3 > income Statement > EBITDA

-1593000

Quarters > 3 > income Statement > operating Margin

-6.54036897440984

Quarters > 3 > income Statement > total Other Income Expense Net

-1666000

Quarters > 3 > balance Sheet > cash

51371000

Quarters > 3 > balance Sheet > short Term Investments

22406000

Quarters > 3 > balance Sheet > receivables

34097000

Quarters > 3 > balance Sheet > inventories

20298000

Quarters > 3 > balance Sheet > total Current Assets

134208000

Quarters > 3 > balance Sheet > property Plant Equipment

12855000

Quarters > 3 > balance Sheet > total Assets

164236000

Quarters > 3 > balance Sheet > payables

7328000

Quarters > 3 > balance Sheet > short Term Debt

582000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

90388000

Quarters > 3 > balance Sheet > equity

73848000

Quarters > 3 > cash Flow > net Income

-5043000

Quarters > 3 > cash Flow > depreciation

668000

Quarters > 3 > cash Flow > change In Working Capital

7898000

Quarters > 3 > cash Flow > cash From Operations

7873000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

14913000

Quarters > 3 > cash Flow > cash From Financing

880000

Quarters > 3 > cash Flow > net Change In Cash

22789000

Quarters > 3 > ratios > PE

-0.05231599149333472

Quarters > 3 > ratios > PB

27.881556711082222

Quarters > 3 > ratios > ROE

-6.828891777705557

Quarters > 3 > ratios > ROA

-3.070581358532843

Quarters > 3 > ratios > FCF

7873000

Quarters > 3 > ratios > Piotroski FScore

2

Quarters > 3 > ratios > fcf Percent

0.15617932949811544

Quarters > 3 > health Score

31

Valuation > metrics > PE

0.0001974801532445989

Valuation > metrics > PB

22.02347019597862

Valuation > final Score

40

Valuation > verdict

267.1% Overvalued

Profitability > metrics > ROE

0.020361415118350726

Profitability > metrics > ROA

0.011612648496742652

Profitability > metrics > Net Margin

0.00025817444847483443

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

1.0305217612624078

Risk > metrics > Interest Coverage

0.8020703933747412

Risk > final Score

33

Risk > verdict

High

Liquidity > metrics > Current Ratio

12.92890924104797

Liquidity > metrics > Quick Ratio

11.134374296224006

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

40

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

61

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

45

Prev Risks > 1

25

Prev Risks > 2

25

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:15:17.200Z